Limits...
A signal-on fluorosensor based on quench-release principle for sensitive detection of antibiotic rapamycin.

Jeong HJ, Itayama S, Ueda H - Biosensors (Basel) (2015)

Bottom Line: We constructed rapamycin Q'-bodies by linking the two interacting domains FKBP12 and FRB, whose association is triggered by rapamycin.The fusion proteins were each incorporated position-specifically with one of fluorescence dyes ATTO520, tetramethylrhodamine, or ATTO590 using a cell-free translation system.As a result, rapid rapamycin dose-dependent fluorescence increase derived of Q'-bodies was observed, especially for those with ATTO520 with a lowest detection limit of 0.65 nM, which indicates its utility as a novel fluorescent biosensor for rapamycin.

View Article: PubMed Central - PubMed

Affiliation: Chemical Resources Laboratory, Tokyo Institute of Technology, 4259-R1-18 Nagatsuta-cho, Midori-ku, Yokohama, 226-8503, Japan. heejin@pe.res.titech.ac.jp.

ABSTRACT
An antibiotic rapamycin is one of the most commonly used immunosuppressive drugs, and also implicated for its anti-cancer activity. Hence, the determination of its blood level after organ transplantation or tumor treatment is of great concern in medicine. Although there are several rapamycin detection methods, many of them have limited sensitivity, and/or need complicated procedures and long assay time. As a novel fluorescent biosensor for rapamycin, here we propose "Q'-body", which works on the fluorescence quench-release principle inspired by the antibody-based quenchbody (Q-body) technology. We constructed rapamycin Q'-bodies by linking the two interacting domains FKBP12 and FRB, whose association is triggered by rapamycin. The fusion proteins were each incorporated position-specifically with one of fluorescence dyes ATTO520, tetramethylrhodamine, or ATTO590 using a cell-free translation system. As a result, rapid rapamycin dose-dependent fluorescence increase derived of Q'-bodies was observed, especially for those with ATTO520 with a lowest detection limit of 0.65 nM, which indicates its utility as a novel fluorescent biosensor for rapamycin.

Show MeSH

Related in: MedlinePlus

Scheme of rapamycin quenchbody (Q’-body) (based on protein data bank entry 1fap [6]).
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4493541&req=5

biosensors-05-00131-f001: Scheme of rapamycin quenchbody (Q’-body) (based on protein data bank entry 1fap [6]).

Mentions: Here, we aimed at developing a novel strategy for configuring a rapamycin biosensor by applying this quench-release principle. We constructed several fluorophore-protein conjugates named Q’-bodies, mimicking the Q-body concept, using an interacting protein pair FKBP12 and FRB whose interaction is mediated by rapamycin (Figure 1).


A signal-on fluorosensor based on quench-release principle for sensitive detection of antibiotic rapamycin.

Jeong HJ, Itayama S, Ueda H - Biosensors (Basel) (2015)

Scheme of rapamycin quenchbody (Q’-body) (based on protein data bank entry 1fap [6]).
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4493541&req=5

biosensors-05-00131-f001: Scheme of rapamycin quenchbody (Q’-body) (based on protein data bank entry 1fap [6]).
Mentions: Here, we aimed at developing a novel strategy for configuring a rapamycin biosensor by applying this quench-release principle. We constructed several fluorophore-protein conjugates named Q’-bodies, mimicking the Q-body concept, using an interacting protein pair FKBP12 and FRB whose interaction is mediated by rapamycin (Figure 1).

Bottom Line: We constructed rapamycin Q'-bodies by linking the two interacting domains FKBP12 and FRB, whose association is triggered by rapamycin.The fusion proteins were each incorporated position-specifically with one of fluorescence dyes ATTO520, tetramethylrhodamine, or ATTO590 using a cell-free translation system.As a result, rapid rapamycin dose-dependent fluorescence increase derived of Q'-bodies was observed, especially for those with ATTO520 with a lowest detection limit of 0.65 nM, which indicates its utility as a novel fluorescent biosensor for rapamycin.

View Article: PubMed Central - PubMed

Affiliation: Chemical Resources Laboratory, Tokyo Institute of Technology, 4259-R1-18 Nagatsuta-cho, Midori-ku, Yokohama, 226-8503, Japan. heejin@pe.res.titech.ac.jp.

ABSTRACT
An antibiotic rapamycin is one of the most commonly used immunosuppressive drugs, and also implicated for its anti-cancer activity. Hence, the determination of its blood level after organ transplantation or tumor treatment is of great concern in medicine. Although there are several rapamycin detection methods, many of them have limited sensitivity, and/or need complicated procedures and long assay time. As a novel fluorescent biosensor for rapamycin, here we propose "Q'-body", which works on the fluorescence quench-release principle inspired by the antibody-based quenchbody (Q-body) technology. We constructed rapamycin Q'-bodies by linking the two interacting domains FKBP12 and FRB, whose association is triggered by rapamycin. The fusion proteins were each incorporated position-specifically with one of fluorescence dyes ATTO520, tetramethylrhodamine, or ATTO590 using a cell-free translation system. As a result, rapid rapamycin dose-dependent fluorescence increase derived of Q'-bodies was observed, especially for those with ATTO520 with a lowest detection limit of 0.65 nM, which indicates its utility as a novel fluorescent biosensor for rapamycin.

Show MeSH
Related in: MedlinePlus